I74

(3R,4R)-4-[[[7-[(phenylmethyl)amino]-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol

Created:	2014-02-28
Last modified:	2017-02-08

Find Related PDB Entry
6 entries where I74 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	2
Bond Count	62
Aromatic Bond Count	16

2D diagram of I74

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3R,4R)-4-[[[7-[(phenylmethyl)amino]-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
Systematic Name (OpenEye OEToolkits)	(3R,4R)-4-[[[7-[(phenylmethyl)amino]-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
Formula	C₂₂ H₃₀ N₆ O
Molecular Weight	394.513
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	n2c(cc(NCc1ccccc1)n3ncc(c23)C(C)C)NCC4CCNCC4O
SMILES	CACTVS	3.385	CC(C)c1cnn2c(NCc3ccccc3)cc(NC[CH]4CCNC[CH]4O)nc12
SMILES	OpenEye OEToolkits	1.9.2	CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NCC4CCNCC4O
Canonical SMILES	CACTVS	3.385	CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]4CCNC[C@@H]4O)nc12
Canonical SMILES	OpenEye OEToolkits	1.9.2	CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NC[C@H]4CCNC[C@@H]4O
InChI	InChI	1.03	InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1
InChIKey	InChI	1.03	YCVGLKWJKIKVBI-MJGOQNOKSA-N

Drug Info: DrugBank

DrugBank ID	DB16061
Name	Samuraciclib
Groups	investigational
Description	Samuraciclib is under investigation in clinical trial NCT03363893 (Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies).
Synonyms	Samuraciclib
CAS number	1805833-75-3

Related Resource References

Resource Name	Reference
PubChem	91844733
ChEMBL	CHEMBL4297488

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.